nifedipine has been researched along with Deep Vein Thrombosis in 2 studies
Nifedipine: A potent vasodilator agent with calcium antagonistic action. It is a useful anti-anginal agent that also lowers blood pressure.
| Excerpt | Relevance | Reference |
|---|---|---|
| "026), avoidance of sublingual nifedipine in patients with acute ischemic stroke (97." | 3.73 | Improved quality of stroke care for hospitalized Medicare beneficiaries in Michigan. ( Baker, PL; Jacobs, BS; Levine, SR; Mehta, RH; Roychoudhury, C, 2005) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jacobs, BS | 1 |
| Baker, PL | 1 |
| Roychoudhury, C | 1 |
| Mehta, RH | 1 |
| Levine, SR | 1 |
| Széplaki, G | 1 |
| Varga, L | 1 |
| Osváth, L | 1 |
| Karádi, I | 1 |
| Füst, G | 1 |
| Farkas, H | 1 |
2 other studies available for nifedipine and Deep Vein Thrombosis
| Article | Year |
|---|---|
Improved quality of stroke care for hospitalized Medicare beneficiaries in Michigan.
Topics: Administration, Sublingual; Aged; Aged, 80 and over; Fee-for-Service Plans; Female; Hospitalization; | 2005 |
Deep venous thrombosis associated with acquired angioedema type II in a patient heterozygous for the mutation of factor V Leiden: effective treatment and follow-up for four years.
Topics: Acenocoumarol; Aged; Angioedema; Autoantibodies; Complement C1 Inhibitor Protein; Danazol; Factor V; | 2006 |